Shields AF - Search Results

1

Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer.

El-Rayes BF, Zalupski MM, Manza SG, Rusin B, Ferris AM, Vaishampayan U, Heilbrun LK, Venkatramanamoorthy R, Shields AF, Philip PA. El-Rayes BF, et al. Among authors: shields af. Cancer Chemother Pharmacol. 2008 Feb;61(2):283-9. doi: 10.1007/s00280-007-0472-1. Epub 2007 Apr 12. Cancer Chemother Pharmacol. 2008. PMID: 17429629 Free PMC article. Clinical Trial.

2

Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma.

Zalupski MM, Philip PA, LoRusso P, Shields AF. Zalupski MM, et al. Among authors: shields af. Cancer Chemother Pharmacol. 1997;40(3):225-7. doi: 10.1007/s002800050650. Cancer Chemother Pharmacol. 1997. PMID: 9219505 Clinical Trial.

3

A phase II study of carboplatin and paclitaxel in the treatment of patients with advanced esophageal and gastric cancer.

Philip PA, Zalupski MM, Gadgeel S, Hussain M, Shields A. Philip PA, et al. Semin Oncol. 1997 Dec;24(6 Suppl 19):S19-86-S19-88. Semin Oncol. 1997. PMID: 9427274 Clinical Trial.

4

Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.

Zalupski MM, Shields AF, Philip PA, Kraut M, LoRusso P, Heilbrun LK, Vaitkevicius V. Zalupski MM, et al. Among authors: shields af. Invest New Drugs. 1998;16(1):93-6. doi: 10.1023/a:1006087114621. Invest New Drugs. 1998. PMID: 9740550 Clinical Trial.

5

Phase II study of CI-958 in colorectal cancer.

Shields AF, Philip PA, LoRusso PM, Ferris AM, Zalupski MM. Shields AF, et al. Cancer Chemother Pharmacol. 1999;43(2):162-4. doi: 10.1007/s002800050878. Cancer Chemother Pharmacol. 1999. PMID: 9923823 Clinical Trial.

6

Gemcitabine and UFT plus oral calcium folinate: phase I study.

Philip PA, Ibrahim D, Zalupski M, Arlauskas P, Shields A. Philip PA, et al. Oncology (Williston Park). 1999 Jul;13(7 Suppl 3):116-9. Oncology (Williston Park). 1999. PMID: 10442378 Free article. Clinical Trial.

7

Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.

Ahmed S, Vaitkevicius VK, Zalupski MM, Du W, Arlauskas P, Gordon C, Kellogg C, Shields AF. Ahmed S, et al. Among authors: shields af. Am J Clin Oncol. 2000 Aug;23(4):420-4. doi: 10.1097/00000421-200008000-00022. Am J Clin Oncol. 2000. PMID: 10955876 Clinical Trial.

8

Cost analysis of pancreatic carcinoma treatment.

Du W, Touchette D, Vaitkevicius VK, Peters WP, Shields AF. Du W, et al. Among authors: shields af. Cancer. 2000 Nov 1;89(9):1917-24. doi: 10.1002/1097-0142(20001101)89:9<1917::aid-cncr7>3.0.co;2-l. Cancer. 2000. PMID: 11064348

9

A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer.

Zonder JA, Shields AF, Zalupski M, Chaplen R, Heilbrun LK, Arlauskas P, Philip PA. Zonder JA, et al. Among authors: shields af. Clin Cancer Res. 2001 Jan;7(1):38-42. Clin Cancer Res. 2001. PMID: 11205915 Clinical Trial.

10

Phase II study of liposomal doxorubicin in patients with advanced colorectal cancer.

Shields AF, Lange LM, Zalupski MM. Shields AF, et al. Am J Clin Oncol. 2001 Feb;24(1):96-8. doi: 10.1097/00000421-200102000-00019. Am J Clin Oncol. 2001. PMID: 11232960 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters